EDGAR Filing Documents for 0001193125-20-245513

Form CORRESP - Correspondence:

SEC Accession No. 0001193125-20-245513

Filing Date

2020-09-14

Accepted

2020-09-14 21:15:28

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	CORRESP	20881
2	GRAPHIC	g940673g52o91.jpg	GRAPHIC	7994
3	GRAPHIC	g940673g55c60.jpg	GRAPHIC	2246
4	GRAPHIC	g940673g78k51.jpg	GRAPHIC	1384
5	GRAPHIC	g940673g90d67.jpg	GRAPHIC	3285
	Complete submission text file	0001193125-20-245513.txt		42892

Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4

Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207

InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations